Aethlon Medical, Inc. (AEMD.OB) Poised to Capitalize on Strategic Biodefense Initiatives
Aethlon Medical, www.aethlonmedical.com – a leading pioneer in the development of sophisticated therapeutic filtration technology for the prevention or amelioration of infectious diseases, including cancer (by removing immunosuppressive agents), reported today the reestablishment of concerted efforts to advance the Aethlon Hemopurifier® as a bioterrorism countermeasure within applicable US governmental programs. The capacity of this revolutionary technology, to selectively target and remove from the circulatory system infectious viruses and immunosuppressive proteins, represents the most advanced and perhaps only truly broad-spectrum countermeasures for weaponized viruses. The Hemopurifier is a very attractive candidate to entities like U.S. Health and Human Services Department (HHS),…